Join to View Full Profile
4340 Newberry RdSte 301Gainesville, FL 32607
Phone+1 352-372-9414
Fax+1 352-271-5393
Dr. Werbel is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Wake Forest University Baptist Medical CenterFellowship, Geriatric Medicine (Internal Medicine), 1992 - 1995- Wake Forest University Baptist Medical CenterFellowship, Endocrinology, Diabetes, and Metabolism, 1994
- Wake Forest University Baptist Medical CenterResidency, Internal Medicine, 1989 - 1992
- Wake Forest University Baptist Medical CenterInternship, Internal Medicine, 1989 - 1990
University of Florida College of MedicineClass of 1989
Certifications & Licensure
FL State Medical License 2005 - 2026
NC State Medical License 1991 - 2006
American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Allscripts Professional EHR, Allscripts, 2012
- Fellow (FACE) American Association of Clinical Endocrinology
Publications & Presentations
PubMed
- 24 citationsInsulin resistance and fat patterning with aging: Relationship to metabolic risk factors for cardiovascular diseaseWilliam T. Cefalu, Sandra Werbel, Audrey D. Bell-Farrow, James G. Terry, Zhong O. Wang
Metabolism. 1998-04-01 - 156 citationsContribution of visceral fat mass to the insulin resistance of aging.William T. Cefalu, Zhong Q. Wang, Sandra Werbel, Audrey D. Bell-Farrow, John R. Crouse
Metabolism. 1995-07-01 - 101 citationsPheochromocytoma. Update on diagnosis, localization, and management.Sandra Werbel, K. Patrick Ober
The Medical Clinics of North America. 1995-01-01
Grant Support
- Inhaled VS Subcutaneous Intensive Insulin In NIDDMNational Center For Research Resources2000–2002
- Inhaled VS Subcutaneous Insulin In Type I DiabetesNational Center For Research Resources2000–2002
- Inhaled VS Subcutaneous Human Insulin In Type II DiabeteNational Center For Research Resources2000–2002
- Inhaled Human Insulin VS Usual SQ Insulin In Type II Diabetes MellitusNational Center For Research Resources2000–2002
- Inhaled Human Insulin VS Usual SQ Insulin In Type I Diabetes MellitusNational Center For Research Resources2000–2002
- Inhaled Human Insulin As Adjunctive Therapy In Subjects With Type 2 DiabetesNational Center For Research Resources2000–2002
- Diabetes Prevention TrialNational Center For Research Resources1996–2002
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
